Similar articles

• Screening data from the cancer chemotherapy National Service Center Screening Laboratories. XLV.

  Schepartz SA, Abbott BJ, Leiter J. Schepartz SA, et al. Cancer Res. 1967 Nov;27(11 Pt 2):1115-283. Cancer Res. 1967. PMID: 4294535 No abstract available.
• Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XL. Plant extracts.

  Abbott BJ, Hartwell JL, Leiter J, Perdue RE Jr, Schepartz SA. Abbott BJ, et al. Cancer Res. 1967 Mar;27(3 Pt 2):190-345. Cancer Res. 1967. PMID: 4289800 No abstract available.
• Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XLI. Plant extracts.

  Abbott BJ, Hartwell JL, Leiter J, Spetzman LA, Schepartz SA. Abbott BJ, et al. Cancer Res. 1967 May;27(5 Pt 2):364-527. Cancer Res. 1967. PMID: 4290629 No abstract available.
• [Antiblastic effects of polycation polyhexamethyleneguanidine, a representative of a new class of antitumor drugs].

  Lidak MIu, Baumanis EA, Zidermane AA, Kagan TI, Zakenfel'd GK, Lisianyĭ NI, Verovskiĭ VN, Birska IA, Zaletok SP, Bramberga VM. Lidak MIu, et al. Vopr Onkol. 1990;36(3):269-76. Vopr Onkol. 1990. PMID: 2184579 Review. Russian. No abstract available.
• Experimental cancer chemotherapy: strategy for cure.

  Cain BF. Cain BF. N Z Med J. 1971 Feb;73(465):85-90. N Z Med J. 1971. PMID: 4994879 Review. No abstract available.